On the public citation graph

A literature mining method to judge whether there are uncertainties in empirical-dependent antineoplastic drug distribution in specific clinical scenarios

0 signed · 51 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/j.1460-2075.1992.tb05481.xopenalex-snapshot
Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.
inferredcites →https://doi.org/10.1002/jcp.26369openalex-snapshot
Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells
inferredcites →https://doi.org/10.1002/tcm.1770050202openalex-snapshot
Cyclophosphamide teratogenesis: A review
inferredcites →https://doi.org/10.1007/s10549-014-3100-xopenalex-snapshot
Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients
inferredcites →https://doi.org/10.1007/s10916-016-0544-zopenalex-snapshot
Using Literature-Based Discovery to Explain Adverse Drug Effects
inferredcites →https://doi.org/10.1016/0006-2952(85)90225-4openalex-snapshot
Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary
inferredcites →https://doi.org/10.1016/0090-8258(91)90004-oopenalex-snapshot
Salvage chemotherapy for ovarian cancer recurrence: Weekly cisplatin in combination with epirubicin or etoposide
inferredcites →https://doi.org/10.1016/j.clbc.2015.03.002openalex-snapshot
Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer
inferredcites →https://doi.org/10.1016/j.drudis.2016.10.008openalex-snapshot
Drug repurposing by integrated literature mining and drug–gene–disease triangulation
inferredcites →https://doi.org/10.1016/j.jbi.2012.04.011openalex-snapshot
A knowledge-driven conditional approach to extract pharmacogenomics specific drug–gene relationships from free text
inferredcites →https://doi.org/10.1016/j.jbi.2013.04.001openalex-snapshot
A semi-supervised approach to extract pharmacogenomics-specific drug–gene pairs from biomedical literature for personalized medicine
inferredcites →https://doi.org/10.1016/j.jbi.2018.09.015openalex-snapshot
PISTON: Predicting drug indications and side effects using topic modeling and natural language processing
inferredcites →https://doi.org/10.1016/j.jpainsymman.2010.02.004openalex-snapshot
Reversal of Dose-Limiting Carboplatin-Induced Peripheral Neuropathy with TRPM8 Activator, Menthol, Enables Further Effective Chemotherapy Delivery
inferredcites →https://doi.org/10.1016/j.ymeth.2014.11.017openalex-snapshot
Prediction of drug gene associations via ontological profile similarity with application to drug repositioning
inferredcites →https://doi.org/10.1016/s1470-2045(08)70285-7openalex-snapshot
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(12)70311-xopenalex-snapshot
Treating cancer as a game
inferredcites →https://doi.org/10.1016/s1470-2045(12)70312-1openalex-snapshot
My Cancer Genome: a unified genomics and clinical trial portal
inferredcites →https://doi.org/10.1016/s1532-0464(03)00014-5openalex-snapshot
Rutabaga by any other name: extracting biological names
inferredcites →https://doi.org/10.1038/nrd1381openalex-snapshot
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
inferredcites →https://doi.org/10.1038/nrgastro.2010.100openalex-snapshot
Hepatocellular carcinoma: a global view
inferredcites →https://doi.org/10.1038/srep44085openalex-snapshot
GEAR: A database of Genomic Elements Associated with drug Resistance
inferredcites →https://doi.org/10.1039/c7mb00020kopenalex-snapshot
Literature-based prediction of novel drug indications considering relationships between entities
inferredcites →https://doi.org/10.1093/bib/bbv087openalex-snapshot
Recent Advances and Emerging Applications in Text and Data Mining for Biomedical Discovery
inferredcites →https://doi.org/10.1093/bib/bbw030openalex-snapshot
Literature-based discovery of new candidates for drug repurposing
inferredcites →https://doi.org/10.1093/bioinformatics/btq667openalex-snapshot
Toward an automatic method for extracting cancer- and other disease-related point mutations from the biomedical literature
inferredcites →https://doi.org/10.1093/database/bav015openalex-snapshot
Colorectal cancer drug target prediction using ontology-based inference and network analysis
inferredcites →https://doi.org/10.1093/jnci/djq530openalex-snapshot
Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer
inferredcites →https://doi.org/10.1093/nar/gku1071openalex-snapshot
Genenames.org: the HGNC resources in 2015
inferredcites →https://doi.org/10.1093/nar/gkv1165openalex-snapshot
DGIdb 2.0: mining clinically relevant drug–gene interactions
inferredcites →https://doi.org/10.1097/00008571-200409000-00002openalex-snapshot
Extracting and characterizing gene???drug relationships from the literature
inferredcites →https://doi.org/10.1097/md.0000000000015001openalex-snapshot
Weekly cisplatin for the treatment of patients with ovarian cancer
inferredcites →https://doi.org/10.1124/mol.109.062836openalex-snapshot
Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
inferredcites →https://doi.org/10.1124/mol.109.063172openalex-snapshot
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
inferredcites →https://doi.org/10.1142/9789812704856_0023openalex-snapshot
BIOLOGICAL NOMENCLATURES: A SOURCE OF LEXICAL KNOWLEDGE AND AMBIGUITY
inferredcites →https://doi.org/10.1186/1471-2105-15-68openalex-snapshot
Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network
inferredcites →https://doi.org/10.1186/1471-2407-13-232openalex-snapshot
Higher rate of skin rash in a phase II trial with weekly nanoparticle albumin-bound paclitaxel and cisplatin combination in Chinese breast cancer patients
inferredcites →https://doi.org/10.1186/1471-2407-13-476openalex-snapshot
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
inferredcites →https://doi.org/10.1186/1744-8069-6-15openalex-snapshot
Transient Receptor Potential Vanilloid 1 is Essential for Cisplatin-Induced Heat Hyperalgesia in Mice
inferredcites →https://doi.org/10.1186/s12859-018-2029-1openalex-snapshot
Deep learning of mutation-gene-drug relations from the literature
inferredcites →https://doi.org/10.1186/s12962-018-0112-0openalex-snapshot
Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China
inferredcites →https://doi.org/10.1186/s13326-017-0125-1openalex-snapshot
Learning from biomedical linked data to suggest valid pharmacogenes
inferredcites →https://doi.org/10.1200/jco.1997.15.5.1938openalex-snapshot
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer.
inferredcites →https://doi.org/10.1200/jco.2000.18.1.106openalex-snapshot
Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study
inferredcites →https://doi.org/10.1371/journal.pcbi.1000943openalex-snapshot
Literature Mining for the Discovery of Hidden Connections between Drugs, Genes and Diseases
inferredcites →https://doi.org/10.1371/journal.pcbi.1004216openalex-snapshot
Learning the Structure of Biomedical Relationships from Unstructured Text
inferredcites →https://doi.org/10.1371/journal.pone.0156091openalex-snapshot
Identifying Liver Cancer and Its Relations with Diseases, Drugs, and Genes: A Literature-Based Approach
inferredcites →https://doi.org/10.2147/ijn.s58275openalex-snapshot
Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer
inferredcites →https://doi.org/10.3389/fgene.2018.00248openalex-snapshot
Prediction of Drug–Gene Interaction by Using Metapath2vec
inferredcites →https://doi.org/10.3389/fimmu.2016.00550openalex-snapshot
The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
inferredcites →https://doi.org/10.3892/or.2018.6710openalex-snapshot
Survival analysis of genome-wide profiles coupled with Connectivity Map database mining to identify potential therapeutic targets for cholangiocarcinoma
inferredcites →https://doi.org/10.4049/jimmunol.166.11.6608openalex-snapshot
Cyclophosphamide Induces the Development of Early Myeloid Cells Suppressing Tumor Cell Growth by a Nitric Oxide-Dependent Mechanism
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.